Recce Pharmaceuticals Stock Performance
| RECEF Stock | 0.22 0.00 0.00% |
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Recce Pharmaceuticals are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Recce Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Recce Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Recce |
Recce Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 22.00 in Recce Pharmaceuticals on September 30, 2025 and sell it today you would earn a total of 0.00 from holding Recce Pharmaceuticals or generate 0.0% return on investment over 90 days. Recce Pharmaceuticals is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Recce, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Recce Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Recce Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Recce Pharmaceuticals, and traders can use it to determine the average amount a Recce Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| RECEF |
Based on monthly moving average Recce Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Recce Pharmaceuticals by adding Recce Pharmaceuticals to a well-diversified portfolio.
Things to note about Recce Pharmaceuticals performance evaluation
Checking the ongoing alerts about Recce Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Recce Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Recce Pharmaceuticals generated a negative expected return over the last 90 days | |
| Recce Pharmaceuticals has some characteristics of a very speculative penny stock |
- Analyzing Recce Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Recce Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Recce Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Recce Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Recce Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Recce Pharmaceuticals' pink sheet. These opinions can provide insight into Recce Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Recce Pink Sheet analysis
When running Recce Pharmaceuticals' price analysis, check to measure Recce Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Recce Pharmaceuticals is operating at the current time. Most of Recce Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Recce Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Recce Pharmaceuticals' price. Additionally, you may evaluate how the addition of Recce Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |